Biopolym. Cell. 2009; 25(3):181-193.
http://dx.doi.org/10.7124/bc.0007DB
Огляди
Біологічна активність глікополімерів базидіальних грибів
1Поліщук О. М., 1Коваленко О. Г.
  1. Інститут мікробіології і вірусології ім. Д. К. Заболотного НАН України
    вул. Академіка Заболотного, 154, Київ, Україна, 03680

Abstract

Проаналізовано літературні дані щодо біологічної активності глікополімерів, одержаних з культуральної рідини, плодових тіл і міцелію базидіальних грибів. Розглянуто структуру та властивості полісахаридів грибів, а також залежність функціонально-біологічної активності від фізико-хімічних характеристик макромолекул. Обговорюються можливості застосування препаратів, отриманих на основі згаданих полісахаридів, для захисту рослин, а також для лікування й профілактики захворювань людини і тварин.
Keywords: Basidiomycetes, грибні полісахариди, структура гліканів базидіоміцетів, хімічні і біологічні властивості гліканів базидіоміцетів
Повний текст: (PDF, українською) (PDF, англійською)

References

[1] Wasser S. P. Reishi or Ling Zhi (Ganoderma lucidum) Encyclopedia of Dietary Suppl Boston, 2005:603–622.
[2] Lindeguist U., Niedermeyer T. H., Julich W. The pharmacological potential of mashrooms. Evid Based Complement Alternat Med. 2005; 2(3):285–299.
[3] Wasser S. P., Didukh M. Ya. Mushroom polysaccharides in human health care Biodiversity of fungi. Their role in human life. Ed. M. K. Rai New York, 2005:289–328.
[4] Ooi V. E. C. Medicinally important fungi Science and Cultivation of Edible. Fungi. 2000; 1:41–51.
[5] Chinara G., Maeda Y. Y., Hamuro J. Current status and perspectives of immunomodulators of microbial origin. Int. J. Tissue Reactions. 1982; 4:207–225.
[6] Wasser S. P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides Appl. Microbiol. and Biotechnol 2002 60, N 3:258–274.
[7] Ikekawa T., Uehara N., Maeda Y., Nakanishi M., Fukuoka F. Antitumor activity of aqueous extracts of edible mushrooms. Cancer Res. 1969; 29(3):734–735.
[8] Hiroshi S., Takeda M. Diverse biological activity of PSK (Krestin), a protein-bound polysaccharide from Coriolus versicolor (Fr.) Quel. Mushroom biology and mushroom products Hong Kong: Chin. Univ. press, 1993:237–245.
[9] Marchessalt R. H., Deslandes Y., Ogawa K., Sundarajan P. R. X-ray diffraction data for -D-glucan. Can. J. Chem. 1977; 55(2):300–303.
[10] Gorin P. A., Barreto-Berger E. The chemistry of polysaccharides of fungi and lichens. The Polysaccharides. 1983; 2:365–409.
[11] Zaidman B.-Z., Yassin M., Mahajna J., Wasser S. P. Medicinal mushroom modulators of molecular targets as cancer therapeutics Appl. Microbiol. and Biotechnol 2005 67, N 4:453–468.
[12] Mizuno T. A. Development of antitumor polysaccharides from mushroom fungi. Foods and Food. Ingred. J. Jap. 1996; 167:69–85.
[13] Mizuno T., Saito H., Nishitoba T., Kawagashi H. Antitumoractive substances from mushrooms. Food Rev. Int. 1995; 11:23–61.
[14] Mizuno T. The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan. Int. J. Med. Mushr. 1999; 1:9–29.
[15] Ovodov Yu. S. Polisacharidy gribov, mchov i lishaynikov, struktura i fiziologicheskaya aktivnost'. Tr. Komi nauch. zentra UrO RAN. 1997; N 156 12p.
[16] Maeda Y. Y., Watanabe S. T., Chihara C., Rokutanda M. Denaturation and renaturation of a -1,6; 1,3-glucan, lentinan associated with expression of T-cell-mediated responses. Cancer Res. 1988; 48(3):671–675.
[17] Yanaki T., Ito W., Tabata K. Correlation between the antitumor activity of a polysaccharide schizophyllan and its triplehelical conformation in dilute aqueous solution Biophys. Chem 1983 17, N 4:337–342.
[18] Puchkova T. A. Glubinnyy mizeliy griba Lentinus edodes: sostav i biologicheskaya aktivnost': Materialy yubileynoy konf., posvyaschennoy 85-letiyu kafedry mikologii i al'gologii MGU im. M. V. Lomonosova Mikologiya i al'golo giya M., 2004 108p.
[19] Ooi V. E., Liu F. A review of pharmacological activities of mushroom polysaccharides. Int. J. Med. Mushr. 1999; 1:195–206.
[20] Yui T., Ogawa K., Kakuta M., Misaki A. Chain conformation of a glucuronoxylomannan isolated from fruit body of Tremella fuciformis Berk J. Carbohydrate Chem 1995 14, N 2:255–263.
[21] Gao Q.-P., Jiang R.-Z., Hui-qun C., Einar J., Rolf S. Characterization and cytokine stimulating activities of heteroglycans from Tremella fuciformis Planta Med 1996 62:297–302.
[22] Vinogradov E., Petersen B. O., Duus J. O., Wasser S. P. The isolation, structure and applications of the exocellular heteropolysaccharide glucuronoxylomannan produced by Yellow Brain Mushroom Tremella mesenterica Ritz.:Fr. (Heterobasidiomycetes) Int. J. Med. Mushr 2004 6, N 4:335–345.
[23] Boldizsar I., Horvath K., Szedlay G., Molnar-Perl I. Simultaneous GC-MS quantitation of acids and sugars in the hydrolyzates of immunostimulants, water soluble polysaccharides of Basidiomycetes. Chromatographia (Germany) 1998 47, N 7–8:413–419.
[24] Mizuno T., Zhuang C., Abe K., Okamoto H., Kiho T., Ukai S., Leclerc S., Meijer L. Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae) Int. J. Med. Mushr 1999 1:301–316.
[25] Zjawiony J. K. Biologically active compounds from Aphyllophorales (polypore) fungi J. Nat. Product 2004 67, N 2:300–310.
[26] Vinogradov E., Wasser S. P. The structure of a polysaccharide isolated from Inonotus levis P. Karst. mushroom (Heterobasidiomycetes) Carbohydrate Res 2005 340, N 18:2821–2825.
[27] Wasser S. P., Weis A. L. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives. Int. J. Med. Mushr. 1999; 1(1):31–62.
[28] Rai M., Tidke G., Wasser S. P. Therapeutic potential of mushrooms. Nat. Prod. Radiance. 2005; 4(4):246–257.
[29] Byerrum RU, Clarke DA, Lucas EH, Ringler RL, Stevens JA, Stock CC. Tumor inhibitors in Boletus edulis and other holobasidiomycetes Antibiot Chemother (Northfield Ill). 1957;7(1):1-4.
[30] Chihara G. Immunopharmacology of lentinan, a polysaccharide isolated from Lentinus edodes. Its application as a host defense potentiator. Int. J. Orient. Med. 1992; 17:55–77.
[31] Ross G. D., Vetvicka V., Yan J., Xia Y., Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer Immunopharmacology 1999 42, N 1–3:61–74.
[32] Kodama N., Komuta K., Nanba H. Effects of D-fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells Biol. Pharm. Bull 2002 25, N 12:1647–1650.
[33] Aoki T. Immune modulation agents and their mechanisms. Immunol. Stud. 1984; 25:62–77.
[34] Uspechi medizinskoy mikologii. Pod red. Yu. V. Sergeeva M., 2001 T. 1 358 p.
[35] Avtonomova A. V., Belizkiy I. V., Isakova E. B., Evsenko M. S., Sedakova L. A., Usov A. I., Treschalina E. M., Tichonov V. P., Buchman V. M., Krasnopol'skaya L. M. Vodorastvorimye polisacharidi mizeliya Ganoderma lucidum: biotechnologiya polucheniya i protivoopucholevye svoystva Materialy 4-go Vseros. kongr. po med. mikologii M., 2006:217–219.
[36] Mizuno T. «Antitumor mushrooms» – Ganoderma lucidum, Grifola frondosa, Lentinus edodes and Agaricus blazei Tokyo: Gendai-shorin, 1997 188 p.
[37] Danilyak M. I., Reshetnikov S. V. Likars'ki gribi. Medichne zastosuvannya ta problemi biotechnologii K., 1996 58 p.
[38] Gunde-Cimerman N. Medicinal value of the genus Pleorotus (Fr.) P. Krast. (Agaricales S. R., Basidiomycetes). Int. J. Med. Mushr. 1999; 1:69–80.
[39] Suzuki S., Oshima S. Influence of Shiitake, Lentinus edodes, on human serum cholesterol. Ann. Rep. Nat. Inst. Nutr. 1974; 25:89–94.
[40] Vincent E. C., Ooi V. E., Liu F. Immunomodulation and anticancer activity of polysaccharide-protein complexes Curr. Med. Chem 2000 7:715–729.
[41] Berger A., Rein D., Kratky E., Monnard I., Hajjaj H., Meirim I., Piguet-Welsch C., Hauser J., Mace K., Niederberger P. Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo and in hamsters and minipigs. Lipids Health Dis 2004 3, N 2:3–20.
[42] Sheng J., Chem Q. Effect of polysaccharides from Auricularia auricular, Tremella fuciformis spores on experimental thrombus formation. Zhongguo Yaoke Daxue Xuebao. 1990; 21:39–42.
[43] Chang H. M., But H. P. P. Pharmacology and applications of chinese materia medica Singapore: World Scientific, 1986 740 p.
[44] Mothana R. A., Jansen R., Julich W. D. Ganomycin A and B, new antimicrobial farnesyl hydroguinones from the basidiomycete Ganoderma prefferi J. Nat. Prod 2000 63:416–418.
[45] Bianco C. Basidiomycetes in relation to antibiosis. Antibiotic activity of mycelia and cultural liquids. Bact. Viral Immunol. 1981; 75:274–627.
[46] Pacumbaba R. P., Caula A. B., Pacumbaba R. O. Shiitake mycelial leachate suppresses growth of some bacterial species and symptoms of bacterial wilt of tomato and lima Bean in vitro Plant Dis 1998 83, N 1:20–23.
[47] Soboleva N. Yu., Krasnopol'skaya L. M., Fedorova G. B., Katrucha G. S. Antibioticheskie svoystva shtamov bazidial'nogo griba Lentinus edodes (Berk.). Sing. Antibiotiki i chimioterapiya. 2006; 51(7):3–8.
[48] Gerasimenya V. P., Efremenkova O. V., Kamzolkina O. V., Bogus T. A., Tolstych I. V., Zenkova V. A. Antimicrobial and antitoxic action of Pleurotus ostreatus (Jacq.:Fr.) Kumm. extracts. Int. J. Med. Mushr 2002 4, N 2:127–132.
[49] Altshul S. Mushroom remedy for chronic yeast infections. Prevention Magazine. 2001; 1:53–60.
[50] Bruggemann R., Orlandi J. M., Benati F. J. Antiviral activity of Agaricus blazei Murrill ss. Heinem extract against human and bovine herpes viruses in cell culture Braz. J. Microbiol. 2006; 37(4):45–51.
[51] Sorimachi K., Ikehara Y., Maezato G., Okubo A., Yamazaki S., Akimoto K., Niwa A. Inhibition by Agaricus blazei Murill fractions of cytopathic effect induced by Western Equine Encephalitis (WEE) virus on VERO cells in vitro Biosci., Biotechnol. and Biochem 2001 65, N 7:1645–1647.
[52] Faccin L. C., Benati F., Rincao V. P., Mantovani M. S., Soares S. A., Gonzaga M. L., Nozawa C., Linhares R. E. Antiviral activity of aqueous and ethanol extracts and of an isolated polysaccharide from Agaricus brasiliensis against poliovirus type 1 Appl. Microbiol 2007 45, N 1:24–28.
[53] Gu C. Q., Li J. W., Chao F., Jin M., Wang X. W., Shen Z. Q. Isolation, identification and function of a novel anti-HSV-1 protein from Grifola frondosa Antiviral Res 2007 75, N 3:250–257.
[54] Li Z1, Liu J, Zhao Y. Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Biochem Mol Biol. 2005;38(1):34-40.
[55] Hijikata Y., Yasuhara A., Sahashi Y. Effect of an herbal formula containing Ganoderma lucidum on reduction of herpes zoster pain: a pilot clinical trial J. Clin. Med 2005 33, N 4:517–523.
[56] Tochikura T. S. Inhibition (in vitro)of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia Med. Microbiol. Immunol 1988 177, N 5:235–244.
[57] Awadh A. N., Mothana R. A., Lesnau A., Pilgrim H., Lindequist U. Antiviral activity of Inonotus hispidus Fitoterapia 2003 74, N 5:483–485.
[58] Wang J., Wang H. X., Ng T. B. A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa Peptides 2007 28, N 3:560–565.
[59] Gu C. Q., Li J., Chao F. H. Inhibition of hepatitis B virus by D-fraction from Grifola frondosa: synergistic effect of combination whith interferon-alpha in HepG2 2.2.15 Antiviral Res 2006 72, N 2:162–165.
[60] Hui S., Zhao C. G., Tong X., Qi Y. P. A lectin with mycelia differentiation and antiphytovirus activities from the edible mushroom Agrocybe aegerita J. Biochem. and Mol. Biol 2003 36, N 2:214–222.
[61] Kovalenko O. G., Polischuk O. M. Effect of glucuronoxylomannan of Tremella mesenterica Ritz. Fr. (Basidiomycota) on the plants resistance to tobacco mosaic virus. Mikrobiol Z. 2009; 71(1):50-6.
[62] Kovalenko O., Polishchuk E. Antiviral activity of glucuronoxylomannan Tremella mesenterica Ritz.Fr. The Young Scientists and Students. Int. Sci. Conf. «Modern Problems of Microbiology and Biotechnology» Odessa, 2007:186.
[63] Sano M., Yoshino K., Matsuzawa T., Ikekawa T. Inhibitory effect of edible higher basidiomycetes mushroom extracts on mouse type IV allergy. Int. J. Med. Mushr 2002 4, N 1:37– 41.